Literature DB >> 17519814

[Pneumothorax following recreational inhalation of nitrous oxide].

L Garbaz1, D Mispelaere, M Boutemy, V Jounieaux.   

Abstract

CASE REPORT: A 21 year old man was admitted to hospital as an emergency complaining of left sided chest pain. Chest radiograph revealed a complete non compressive left-sided pneumothorax which resolved following thoracic drainage. A more detailed history revealed repeated and regular use of nitrous oxide by inhalation, for its consciousness-altering effect during rave parties. DISCUSSION: The principal side effects occurring as a consequence of repeated exposures to nitrous oxide are haematological, neuropsychiatric and teratogenic. Rare cases of pneumothorax have been described associated with the use of nitrous oxide occurring as complications of anaesthesia or during laparoscopy where gas diffuses from the abdominal to the pleural cavity. Illicit use of nitrous oxide is rare and usually occurs in medical workers. Its spreading to the public may lead to accidents and unanticipated side effects.
CONCLUSION: Inhaled nitrous oxide can reveal asymptomatic pneumothorax by worsening it. The consequences can be dramatic in case of illicit use because of ignorance of side effects.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17519814     DOI: 10.1016/s0761-8425(07)91130-4

Source DB:  PubMed          Journal:  Rev Mal Respir        ISSN: 0761-8425            Impact factor:   0.622


  2 in total

1.  The MEOPAeDent trial protocol-an observational study of the Equimolar Mixture of Oxygen and Nitrous Oxide (EMONO) effects in paediatric dentistry.

Authors:  Tony Prud'homme; Sylvie Dajean-Trutaud; Morgane Rousselet; Fanny Feuillet; Marjorie Carpentier-Cheraud; Olivier Bonnot; Isabelle Hyon; Marie Grall-Bronnec; Serena Lopez-Cazaux; Caroline Victorri-Vigneau
Journal:  BMC Oral Health       Date:  2019-03-07       Impact factor: 2.757

2.  PHEDRE trial protocol - observational study of the prevalence of problematic use of Equimolar Mixture of Oxygen and Nitrous Oxide (EMONO) and analgesics in the French sickle-cell disease population.

Authors:  Marie Gérardin; Marie-Laure Couec; Marie Grall-Bronnec; Fanny Feuillet; Laura Wainstein; Morgane Rousselet; Marie-Lyne Pinot; Fanny Perrouin; Olivier Bonnot; Marie-Hélène Drouineau; Pascale Jolliet; Caroline Victorri-Vigneau
Journal:  BMC Psychiatry       Date:  2015-11-14       Impact factor: 3.630

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.